...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: May thru October 2020
3
Apr 21, 2020 10:10AM
3
Apr 21, 2020 10:44AM
2
Apr 21, 2020 02:12PM
2
Apr 21, 2020 07:18PM

That would be the expiration of the debenture financing.  If it expires without repayment, the intellectual property is collateral and would be owned by the debenture issuer.

 

However, this is assuming that absolutely no partnership takes place with the break through therapy designation. Or that we sell the company (or Apabetalone for a tidy sum). Or that the deep pocketed investors won’t step in and save the company from such a ridiculous fate. Or, at the very least, that we cannot come up with additional financing to pay off the loan and buy more time.

 

It’s worst case scenario (and does not seem all that realistic considering the data, FDA breakthrough designation, etc).

9
Apr 22, 2020 06:30AM
1
Apr 22, 2020 09:55AM
Share
New Message
Please login to post a reply